ukmla MCQ (SBA): COPD (Chronic Management)

Instant feedback + full explanation. One question, done properly.

MediumRespiratory MedicineCOPD (Chronic Management)ukmlamrcgp aktpanemrcem sbamrcp part 1prescribing safety assessment

A 60-year-old man with moderate COPD (FEV1 60% predicted) is using a SABA and a LABA/LAMA combination inhaler. He has had 3 moderate exacerbations in the past year. His blood eosinophil count is 0.35 x 10^9/L. What is the most appropriate next step in his inhaled therapy?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: COPD (Chronic Management) — Answer & Explanation | iatroX